6.
Valero-Munoz M, Backman W, Sam F
. Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition". JACC Basic Transl Sci. 2018; 2(6):770-789.
PMC: 5764178.
DOI: 10.1016/j.jacbts.2017.07.013.
View
7.
Arrigo M, Huber L
. Eponyms in cardiopulmonary reflexes. Am J Cardiol. 2013; 112(3):449-53.
DOI: 10.1016/j.amjcard.2013.03.055.
View
8.
Snow J, Kanagy N, Walker B, Resta T
. Rat strain differences in pulmonary artery smooth muscle Ca(2+) entry following chronic hypoxia. Microcirculation. 2009; 16(7):603-14.
PMC: 2997640.
DOI: 10.1080/10739680903114268.
View
9.
Bursi F, McNallan S, Redfield M, Nkomo V, Lam C, Weston S
. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol. 2012; 59(3):222-31.
PMC: 3258551.
DOI: 10.1016/j.jacc.2011.06.076.
View
10.
Rai N, Sydykov A, Kojonazarov B, Wilhelm J, Manaud G, Veeroju S
. Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension. Eur Respir J. 2022; 60(2).
PMC: 9403440.
DOI: 10.1183/13993003.01698-2021.
View
11.
Adir Y, Guazzi M, Offer A, Temporelli P, Cannito A, Ghio S
. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities. Am Heart J. 2017; 192:120-127.
DOI: 10.1016/j.ahj.2017.06.006.
View
12.
Lam C, Croatt A, Richardson D, Nath K, Katusic Z
. Heart failure increases protein expression and enzymatic activity of heme oxygenase-1 in the lung. Cardiovasc Res. 2004; 65(1):203-10.
DOI: 10.1016/j.cardiores.2004.09.001.
View
13.
Amirjanians M, Egemnazarov B, Sydykov A, Kojonazarov B, Brandes R, Luitel H
. Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension. Oncotarget. 2017; 8(18):29613-29624.
PMC: 5444690.
DOI: 10.18632/oncotarget.16769.
View
14.
Fayyaz A, Edwards W, Maleszewski J, Konik E, DuBrock H, Borlaug B
. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction. Circulation. 2017; 137(17):1796-1810.
PMC: 5915920.
DOI: 10.1161/CIRCULATIONAHA.117.031608.
View
15.
Garcia-Lunar I, Pereda D, Santiago E, Solanes N, Nuche J, Ascaso M
. Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study. Basic Res Cardiol. 2019; 114(2):5.
DOI: 10.1007/s00395-018-0714-x.
View
16.
Lam C, Roger V, Rodeheffer R, Borlaug B, Enders F, Redfield M
. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009; 53(13):1119-26.
PMC: 2736110.
DOI: 10.1016/j.jacc.2008.11.051.
View
17.
LaBourene J, Coles J, Johnson D, Mehra A, Keeley F, Rabinovitch M
. Alterations in elastin and collagen related to the mechanism of progressive pulmonary venous obstruction in a piglet model. A hemodynamic, ultrastructural, and biochemical study. Circ Res. 1990; 66(2):438-56.
DOI: 10.1161/01.res.66.2.438.
View
18.
Aguero J, Ishikawa K, Hadri L, Santos-Gallego C, Fish K, Hammoudi N
. Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. Am J Physiol Heart Circ Physiol. 2014; 307(8):H1204-15.
PMC: 4200337.
DOI: 10.1152/ajpheart.00246.2014.
View
19.
Huston J, Shah S
. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Circ Res. 2022; 130(9):1382-1403.
PMC: 9060387.
DOI: 10.1161/CIRCRESAHA.122.319967.
View
20.
Stenmark K, Meyrick B, Galie N, Mooi W, McMurtry I
. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009; 297(6):L1013-32.
DOI: 10.1152/ajplung.00217.2009.
View